Benaroya Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Benaroya Research Institute sits in the top decile of US sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count).
Benaroya Research Institute: 28 sponsored US clinical trials, 4 recruiting.
Benaroya Research Institute sponsors 28 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 23 completed. 4 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pain, with 2 trials.
Top-decile sponsor footprint
Benaroya Research Institute ranks in the top decile of sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
23 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
28 total, page 1 of 1
Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms
NCT07377929
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population
NCT06585540
Antibiotic Usage Prior to OnabotulinumtoxinA Injection
NCT04754737
Optimizing Pain Control in Transurethral Resection of the Prostate
NCT04102566
Do Patient Educational Videos Improve Pain and Recovery After Laparoscopic Hysterectomy?
NCT06265376
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
NCT05281614
Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D
NCT05847413
Opioid-free Anesthesia for Open Cardiac Surgery: A Prospective Randomized Controlled Trial
NCT04197570
Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients
NCT06453993
Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty
NCT04821245
Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes
NCT06314516
Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy
NCT04098809
Transversus Abdominus Plane Catheters for Open Inguinal Hernia Repair
NCT02741492
Proximal Versus Distal Adductor Canal Blocks for Total Knee Arthroplasty
NCT02701114
Evaluation of Supraclavicular, Suprascapular, and Interscalene Nerve Blocks for Outpatient Shoulder Surgery
NCT02287142
Comparison of Pulmonary Function and Efficacy of Different Nerve Block Catheters for Shoulder Surgery
NCT02117778
Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults
NCT01650870
Intraoperative Radiation Therapy in Early Stage Breast Cancer
NCT02266602
Study on the Safety of Abatacept in Relapsing Polychondritis
NCT01272856
Kristalose as Bowel Evacuant Prior to Colonoscopy
NCT01256541
Neuraxial Ultrasound for Thoracic Epidural Placement
NCT02785055
Effects of Perioperative B&O Suppositories on Post-op Pain and Morphine Use After Laparoscopic Prostatectomy
NCT00863928
Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT
NCT00761241
Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
NCT00577356
Preventing Propofol-associated Injection Pain
NCT00864682
Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers
NCT00343044
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
NCT00349557
Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer
NCT00242918
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 3 | 2 |
| Phase 4 | 2 |
What is open in the Benaroya Research Institute pipeline
4 recruiting of 28 indexed (14% open); 23 completed (82%).
Phase mix: 4 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Pain (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Benaroya Research Institute: open-pipeline peers nationwide
Peers matched on 28 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Benaroya Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 28 trials (± recruiting share)
- Axsome Therapeutics · 28 trials · 21% recruiting
- CAMC Health System · 28 trials · 11% recruiting
- CTI BioPharma · 28 trials · 0% recruiting
- Harvard Pilgrim Health Care · 28 trials · 4% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Benaroya Research Institute page
28 registered trials is a research-attention snapshot, not an endorsement of Benaroya Research Institute or any single study.
- 4 of Benaroya Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pain is the condition Benaroya Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Benaroya Research Institute pipeline card: 28 registered trials from official public datasets.Report a data error.